Home › Trials › Breast

Breast cancer

To see the safety and effectiveness NuvastaticÃ?Â® 300 mg in reducing chemotherapy induced fatigue in patients with metastatic triple negative breast cancer receiving standard chemotherapy

Who can joinAsk the trial team

AgeAsk the trial team

Kind of studyPhase 3: compared with usual treatment

What it testsA medicine

The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.

Contact hospital

The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.

Ardent Clinical Research ServicesPuneDirections ↗

Registry summary (technical)

A randomized double blind placebo controlled multicenter phase III study to evaluate the efficacy and safety of NuvastaticÃ?Â® 300 mg in reducing chemotherapy induced fatigue in patients with metastatic triple negative breast cancer receiving standard chemotherapy - NIL

Sponsor: Natureceuticals Sdn Bhd
CTRI/2024/11/076299 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 1 Jun 2026 · read by us 5 Nov 2026

Need help reaching the trial team? Write to us.

Tell us the city, the type of cancer and the trial number if you have one. We reply in simple words within 3 working days.

ट्रायल टीम से जुड़ने में मदद चाहिए? हमें ईमेल करें।

ట్రయల్ టీమ్‌ను సంప్రదించడానికి సహాయం కావాలా? మాకు ఈమెయిల్ చేయండి.

சோதனைக் குழுவை தொடர்பு கொள்ள உதவி வேண்டுமா? எங்களுக்கு மின்னஞ்சல் செய்யுங்கள்.